Executive Vice President and Chief Science Officer, professor, DVM, PhD, DSc, 20 years of experience in R&D leadership of the value chain involved in discovery, development and approval of innovative biological medicines within diabetes and other Novo Nordisk focus areas. Since 2000 Executive Vice President and Chief Science Officer responsible for Novo Nordisk's Research and Development organis...